Dopaminergic cell damage and vulnerability to MPTP in Pink1 knockdown zebrafish

Neurobiology of Disease

Volumn 40, Issue 1, 2010, Pages 93-101

  Sallinen, Ville ^a   Kolehmainen, Juha ^a   Priyadarshini, Madhusmita ^a   Toleikyte, Gabija ^a   Chen, Yu Chia ^a   Panula, Pertti ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Diencephalon; Dopamine; Morpholino oligonucleotide; Neurodegeneration; Park6; Parkinson's disease; Translation inhibition; Tyrosine hydroxylase

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; GENE PRODUCT; MESSENGER RNA; MORPHOLINO OLIGONUCLEOTIDE; OLIGONUCLEOTIDE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE INDUCED PUTATIVE KINASE; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL POPULATION; CONTROLLED STUDY; CYTOTOXICITY; DIENCEPHALON; DOPAMINERGIC NERVE CELL; EMBRYO; GENE EXPRESSION; GENE LOSS; GENE TARGETING; IMMUNOREACTIVITY; LARVAL STAGE; MOTOR DYSFUNCTION; NERVE CELL LESION; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RNA SPLICING; SENSITIZATION; ZEBRA FISH;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; DISEASE MODELS, ANIMAL; GENE KNOCKDOWN TECHNIQUES; MODELS, GENETIC; NEURONS; NEUROTOXINS; PARKINSONIAN DISORDERS; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES;

EID: 77955843574     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2010.06.001     Document Type: Article

References (49)

1. Anichtchik O., Diekmann H., Fleming A., Roach A., Goldsmith P., Rubinsztein D.C. Loss of PINK1 function affects development and results in neurodegeneration in zebrafish. J Neurosci 2008, 28:8199-8207.
2. Anichtchik O.V., Kaslin J., Peitsaro N., Scheinin M., Panula P. Neurochemical and behavioural changes in zebrafish Danio rerio after systemic administration of 6-hydroxydopamine and 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine. J Neurochem 2004, 88:443-453.
3. Beal M.F. Experimental models of Parkinson's disease. Nat Rev Neurosci 2001, 2:325-334.
4. Blackinton J.G., Anvret A., Beilina A., Olson L., Cookson M.R., Galter D. Expression of PINK1 mRNA in human and rodent brain and in Parkinson's disease. Brain Res 2007, 1184:10-16.
5. Bonifati V., Rizzu P., Squitieri F., Krieger E., Vanacore N., van Swieten J.C., Brice A., van Duijn C.M., Oostra B., Meco G., Heutink P. DJ-1( PARK7), a novel gene for autosomal recessive, early onset parkinsonism. Neurol Sci 2003, 24:159-160.
6. Bretaud S., Lee S., Guo S. Sensitivity of zebrafish to environmental toxins implicated in Parkinson's disease. Neurotoxicol Teratol 2004, 26:857-864.
7. Candy J., Collet C. Two tyrosine hydroxylase genes in teleosts. Biochim Biophys Acta 2005, 1727:35-44.
8. Chen Y.C., Priyadarshini M., Panula P. Complementary developmental expression of the two tyrosine hydroxylase transcripts in zebrafish. Histochem Cell Biol 2009, 132:375-381.
9. Clark I.E., Dodson M.W., Jiang C., Cao J.H., Huh J.R., Seol J.H., Yoo S.J., Hay B.A., Guo M. Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 2006, 441:1162-1166.
10. Eisen J.S., Smith J.C. Controlling morpholino experiments: don't stop making antisense. Development 2008, 135:1735-1743.
11. Ephraty L., Porat O., Israeli D., Cohen O.S., Tunkel O., Yael S., Hatano Y., Hattori N., Hassin-Baer S. Neuropsychiatric and cognitive features in autosomal-recessive early parkinsonism due to PINK1 mutations. Mov Disord 2007, 22:566-569.
12. Exner N., Treske B., Paquet D., Holmstrom K., Schiesling C., Gispert S., Carballo-Carbajal I., Berg D., Hoepken H.H., Gasser T., Kruger R., Winklhofer K.F., Vogel F., Reichert A.S., Auburger G., Kahle P.J., Schmid B., Haass C. Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin. J Neurosci 2007, 27:12413-12418.
13. Filippi A., Mahler J., Schweitzer J., Driever W. Expression of the paralogous tyrosine hydroxylase encoding genes th1 and th2 reveals the full complement of dopaminergic and noradrenergic neurons in zebrafish larval and juvenile brain. J Comp Neurol 2010, 518:423-438.
14. Fink M., Flekna G., Ludwig A., Heimbucher T., Czerny T. Improved translation efficiency of injected mRNA during early embryonic development. Dev Dyn 2006, 235:3370-3378.
15. Fiorio M., Valente E.M., Gambarin M., Bentivoglio A.R., Ialongo T., Albanese A., Barone P., Pellecchia M.T., Brancati F., Moretto G., Fiaschi A., Tinazzi M. Subclinical sensory abnormalities in unaffected PINK1 heterozygotes. J Neurol 2008, 255:1372-1377.
16. Flinn L., Mortiboys H., Volkmann K., Koster R.W., Ingham P.W., Bandmann O. Complex I deficiency and dopaminergic neuronal cell loss in parkin-deficient zebrafish (Danio rerio). Brain 2009, 132:1613-1623.
17. Gandhi S., Muqit M.M., Stanyer L., Healy D.G., Abou-Sleiman P.M., Hargreaves I., Heales S., Ganguly M., Parsons L., Lees A.J., Latchman D.S., Holton J.L., Wood N.W., Revesz T. PINK1 protein in normal human brain and Parkinson's disease. Brain 2006, 129:1720-1731.
18. Hornykiewicz O., Kish S.J. Biochemical pathophysiology of Parkinson's disease. Adv Neurol 1987, 45:19-34.
19. Kaslin J., Nystedt J.M., Ostergard M., Peitsaro N., Panula P. The orexin/hypocretin system in zebrafish is connected to the aminergic and cholinergic systems. J Neurosci 2004, 24:2678-2689.
20. Kaslin J., Panula P. Comparative anatomy of the histaminergic and other aminergic systems in zebrafish (Danio rerio). J. Comp. Neurol. 2001, 440:342-377.
21. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Yokochi M., Mizuno Y., Shimizu N. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998, 392:605-608.
22. Kitada T., Pisani A., Porter D.R., Yamaguchi H., Tscherter A., Martella G., Bonsi P., Zhang C., Pothos E.N., Shen J. Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice. Proc Natl Acad Sci U S A 2007, 104:11441-11446.
23. Lam C.S., Korzh V., Strahle U. Zebrafish embryos are susceptible to the dopaminergic neurotoxin MPTP. Eur J Neurosci 2005, 21:1758-1762.
24. Marcus R.C., Easter S.S. Expression of glial fibrillary acidic protein and its relation to tract formation in embryonic zebrafish (Danio rerio). J Comp Neurol 1995, 359:365-381.
25. McKinley E.T., Baranowski T.C., Blavo D.O., Cato C., Doan T.N., Rubinstein A.L. Neuroprotection of MPTP-induced toxicity in zebrafish dopaminergic neurons. Brain Res Mol Brain Res 2005, 141:128-137.
26. Mills R.D., Sim C.H., Mok S.S., Mulhern T.D., Culvenor J.G., Cheng H.C. Biochemical aspects of the neuroprotective mechanism of PTEN-induced kinase-1 (PINK1). J Neurochem 2008, 105:18-33.
27. Murakami T., Moriwaki Y., Kawarabayashi T., Nagai M., Ohta Y., Deguchi K., Kurata T., Morimoto N., Takehisa Y., Matsubara E., Ikeda M., Harigaya Y., Shoji M., Takahashi R., Abe K. PINK1, a gene product of PARK6, accumulates in alpha-synucleinopathy brains. J Neurol Neurosurg Psychiatry 2007, 78:653-654.
28. Nicklas W.J., Youngster S.K., Kindt M.V., Heikkila R.E. MPTP, MPP+ and mitochondrial function. Life Sci 1987, 40:721-729.
29. Paisan-Ruiz C., Jain S., Evans E.W., Gilks W.P., Simon J., van der B.M., Lopez d.M., Aparicio S., Gil A.M., Khan N., Johnson J., Martinez J.R., Nicholl D., Carrera I.M., Pena A.S., de Silva R., Lees A., Marti-Masso J.F., Perez-Tur J., Wood N.W., Singleton A.B. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 2004, 44:595-600.
30. Panula P., Sallinen V., Sundvik M., Kolehmainen J., Torkko V., Tiittula A., Moshnyakov M., Podlasz P. Modulatory neurotransmitter systems and behavior: towards zebrafish models of neurodegenerative diseases. Zebrafish 2006, 3:235-247.
31. Park J., Lee G., Chung J. The PINK1-parkin pathway is involved in the regulation of mitochondrial remodeling process. Biochem Biophys Res Commun 2009, 378:518-523.
32. Park J., Lee S.B., Lee S., Kim Y., Song S., Kim S., Bae E., Kim J., Shong M., Kim J.M., Chung J. Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 2006, 441:1157-1161.
33. Peitsaro N., Kaslin J., Anichtchik O.V., Panula P. Modulation of the histaminergic system and behaviour by alpha-fluoromethylhistidine in zebrafish. J. Neurochem. 2003, 86:432-441.
34. Petit A., Kawarai T., Paitel E., Sanjo N., Maj M., Scheid M., Chen F., Gu Y., Hasegawa H., Salehi-Rad S., Wang L., Rogaeva E., Fraser P., Robinson B., George-Hyslop P., Tandon A. Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations. J Biol Chem 2005, 280:34025-34032.
35. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di Iorio G., Golbe L.I., Nussbaum R.L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997, 276:2045-2047.
36. Poole A.C., Thomas R.E., Andrews L.A., McBride H.M., Whitworth A.J., Pallanck L.J. The PINK1/Parkin pathway regulates mitochondrial morphology. Proc Natl Acad Sci U S A 2008, 105:1638-1643.
37. Pridgeon J.W., Olzmann J.A., Chin L.S., Li L. PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1. PLoS Biol 2007, 5:e172.
38. Riederer P., Wuketich S. Time course of nigrostriatal degeneration in Parkinson's disease. A detailed study of influential factors in human brain amine analysis. J Neural Transm 1976, 38:277-301.
39. Rink E., Wullimann M.F. The teleostean (zebrafish) dopaminergic system ascending to the subpallium (striatum) is located in the basal diencephalon (posterior tuberculum). Brain Res 2001, 889:316-330.
40. Robu M.E., Larson J.D., Nasevicius A., Beiraghi S., Brenner C., Farber S.A., Ekker S.C. p53 activation by knockdown technologies. PLoS Genet 2007, 3:e78.
41. Sallinen V., Sundvik M., Reenila I., Peitsaro N., Khrustalyov D., Anichtchik O., Toleikyte G., Kaslin J., and Panula P. (2009a). Hyperserotonergic phenotype after monoamine oxidase inhibition in larval zebrafish. J Neurochem 109, 403-415.
42. Sallinen V., Torkko V., Sundvik M., Reenila I., Khrustalyov D., Kaslin J., Panula P. MPTP and MPP+ target specific aminergic cell populations in larval zebrafish. J Neurochem 2009, 108:719-731.
43. Taymans J.M., Van den H.C., Baekelandt V. Distribution of PINK1 and LRRK2 in rat and mouse brain. J Neurochem 2006, 98:951-961.
44. Thisse C., Thisse B. High-resolution in situ hybridization to whole-mount zebrafish embryos. Nat Protoc 2008, 3:59-69.
45. Valente E.M., Abou-Sleiman P.M., Caputo V., Muqit M.M., Harvey K., Gispert S., Ali Z., Del Turco D., Bentivoglio A.R., Healy D.G., Albanese A., Nussbaum R., Gonzalez-Maldonado R., Deller T., Salvi S., Cortelli P., Gilks W.P., Latchman D.S., Harvey R.J., Dallapiccola B., Auburger G., Wood N.W. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 2004, 304:1158-1160.
46. Wang D., Qian L., Xiong H., Liu J., Neckameyer W.S., Oldham S., Xia K., Wang J., Bodmer R., Zhang Z. Antioxidants protect PINK1-dependent dopaminergic neurons in Drosophila. Proc Natl Acad Sci U S A 2006, 103:13520-13525.
47. Yang Y., Gehrke S., Imai Y., Huang Z., Ouyang Y., Wang J.W., Yang L., Beal M.F., Vogel H., Lu B. Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by parkin. Proc Natl Acad Sci U S A 2006, 103:10793-10798.
48. Zhou C., Huang Y., Shao Y., May J., Prou D., Perier C., Dauer W., Schon E.A., Przedborski S. The kinase domain of mitochondrial PINK1 faces the cytoplasm. Proc Natl Acad Sci U S A 2008, 105:12022-12027.
49. Zhou H., Falkenburger B.H., Schulz J.B., Tieu K., Xu Z., Xia X.G. Silencing of the Pink1 gene expression by conditional RNAi does not induce dopaminergic neuron death in mice. Int J Biol Sci 2007, 3:242-250.